Add BrightSurf on Google Email

New cancer drug candidate targets immune system “brakes”

Researchers have designed a potential therapeutic that dampens the activity of regulatory T cells, which can prevent the immune system from unleashing its full potential against tumor cells. The molecule, known as FOX3P, acts as a transcription factor for many Treg genes but isn't vital for other types of T cells.

SourceUniversity of Chicago·JournalProceedings of the National Academy of Sciences·DateOct 18, 2022

Cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines, according to JNCCN study

Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateOct 17, 2022

Infections can have long-term consequences

A VUB study has mapped the immune system's response to brain infections, revealing that resident macrophages play a key role in defending against pathogens. The researchers found that blood-derived immune cells can eliminate parasites, but may retain 'memory' of past infections, altering their ability to respond to future insults.

SourceVrije Universiteit Brussel·JournalImmunity·DateOct 12, 2022

Moffitt researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

Researchers found that high PERK activity correlates with poorer outcomes and lower anti-tumor immune cells in patients with melanoma. Inhibition of PERK promoted a type of cell death called paraptosis, which involved trafficking of immune cells to tumors and matured dendritic cells triggering anti-tumor T cell immunity.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalCancer Cell·TypeExperimental study·DateOct 10, 2022

Random defense: Cells play ‘molecular roulette’ to determine how body fights disease

Researchers discovered that B cells randomly allocate antibody classes to fight infections and diseases, leading to varying probabilities of developing conditions like asthma. This 'molecular roulette' process can be predicted using a formula, paving the way for understanding individual susceptibility.

SourceWalter and Eliza Hall Institute·JournalImmunity·TypeComputational simulation/modeling·DateOct 4, 2022

Paris will host the 9th Annual Meeting of the International Society of Microbiota dedicated to microbiota and microbiotal medicine: Where we are now and what’s next?

The event will cover various topics including microbiota dysbiosis, oral and vaginal microbiota, and their impact on diseases like depression, cancer, and respiratory infections. The meeting aims to accelerate Microbiota medicine applications through strategic discussions.

Disarming the body’s defenders

A study published in Science reveals that tumor cells with a specific mutation release a chemical metabolite that weakens nearby immune cells, rendering them less capable of killing cancer cells. The findings highlight the critical role of the tumor microenvironment in cancer growth and provide insights into developing targeted therapi...

SourceHarvard Medical School·JournalScience·DateSep 29, 2022

Immune cells more susceptible to being suppressed allow acceptance of transplanted organs

In a new study, researchers found that immune T cells lacking the key transcription factor Satb1 are more susceptible to suppression by regulatory T cells, leading to transplant tolerance. The study provides insight into the mechanism behind transplantation tolerance and may lead to the development of new immunosuppression regimens.

SourceUniversity of Chicago·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 26, 2022

Tiny sea creature’s genes shed light on evolution of immunity

Researchers have identified a complex of proteins in a tiny marine invertebrate that share similarities with the human immune system, suggesting an earlier origin for the building blocks of our immune system. The study could ultimately guide the development of new immunotherapies and improve understanding of transplant rejection.

SourceUniversity of Pittsburgh·JournalProceedings of the National Academy of Sciences·DateSep 26, 2022

A consistent lack of sleep negatively impacts immune stem cells, increasing risk of inflammatory disorders and heart disease

A new study finds that consistently losing an hour and a half of sleep per night can negatively impact immune stem cells, leading to increased inflammation and cardiovascular disease. Even after catching up on sleep, the effects of disrupted sleep remain long-lasting.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of Experimental Medicine·TypeExperimental study·DateSep 21, 2022

Stowers scientists use zebrafish to understand the connection between the immune system and regeneration

Stowers scientists investigate macrophage activation states in zebrafish sensory organ, discovering three distinct anti-inflammatory pathways that may inform human regenerative immunotherapies. The study provides valuable insights into the timing and genetic programs of macrophages, a type of white blood cell, in repair and regeneration.

SourceStowers Institute for Medical Research·JournalNature Communications·TypeExperimental study·DateSep 20, 2022

Researchers discover dozens of genetic defects important for immune defence - relevant for patients with rare diseases

Two studies identify 22 previously unreported NFKB1 variants linked to immune system dysfunction, including reduced expression of the protein and altered gene expression. The findings suggest targeted inhibition of NFkB signaling pathway components as an attractive therapeutic approach for treating these diseases.

SourceUniversity of Helsinki·JournalFrontiers in Immunology·DateSep 20, 2022

New mechanism extends life of immune system

Researchers discovered a telomere transfer reaction between immune cells that extends their lifespan and confers long-term protection. This 'anti-ageing' mechanism has potential clinical applications for diseases like cancer and dementia, and may enable people to live healthier and longer.

SourceUniversity College London·JournalNature Cell Biology·TypeExperimental study·DateSep 15, 2022

Immunotherapy reduces lung and liver fibrosis in mice

Researchers at the University of Zurich have developed a new immunotherapy strategy to eliminate fibroblasts in targeted manner, reducing lung and liver fibrosis in mice. The treatment triggers an immune response via cytotoxic T-cells, eliminating activated connective tissue cells while leaving resting cells undamaged.

SourceUniversity of Zurich·JournalCell Stem Cell·TypeExperimental study·DateSep 15, 2022

Infants, young children finally get relief from eczema’s terrible itch

A new biologic drug has been found to be highly effective in reducing the signs and symptoms of moderate-to-severe eczema in infants and young children. The study showed that more than half of treated children experienced a 75% reduction in eczema symptoms, leading to improved sleep and increased ability to lead normal lives.

SourceNorthwestern University·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateSep 15, 2022

Chlamydia’s stealthy cloaking device identified

Researchers at Duke University have discovered a protein called GarD that cloaks Chlamydia bacteria from the host cell's immune system, allowing it to evade detection and elimination. Mutating this protein makes the bacteria vulnerable to destruction, offering new avenues for treatment.

SourceDuke University·JournalCell Host & Microbe·TypeExperimental study·DateSep 8, 2022

Those suffering from autoimmune diseases require a third coronavirus vaccination

A study published in The Lancet Rheumatology found that booster vaccinations significantly increase immune protection for individuals with autoimmune diseases such as rheumatism and inflammatory bowel disease. Most patients experienced no significant side effects after receiving a third vaccination, and their antibodies effectively pro...

SourceFriedrich-Alexander-Universität Erlangen-Nürnberg·JournalThe Lancet Rheumatology·DateSep 2, 2022

Returning to football after COVID-19 infection

A study by LSU found that elite student-athletes could safely return to practice and play football after COVID-19 isolation, with their immune system returning to baseline levels. This contrasts with older adults with comorbidities, who are at higher risk for serious side effects.

SourceLouisiana State University·JournalScientific Reports·TypeExperimental study·DateAug 30, 2022

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

Researchers at LSU Health New Orleans have identified a critical immunosuppressive pathway and developed an experimental inhibitor to protect T-cells from weakening. The CBL-B inhibitors show great potential in enhancing the efficacy of cancer immunotherapy, making patients' T-cells more effective in killing cancer cells.

SourceLouisiana State University Health Sciences Center·JournalFrontiers in Immunology·TypeExperimental study·DateAug 29, 2022

Plants reprogram their cells to fight invaders. Here's how

Researchers have discovered the key components in plant cells that trigger 'wartime' protein production in response to pathogens. This mechanism allows plants to rapidly produce defense proteins while balancing resources between growth and defense, a delicate process that could inform strategies for creating disease-resistant crops.

SourceDuke University·JournalCell·TypeExperimental study·DateAug 25, 2022

DNA guardians out of control

Scientists at the University of Bonn discovered that an overactivated cGAS/STING signaling pathway leads to severe inflammation in ANCA-associated vasculitis. The study involved patients with the disease and a novel mouse model, providing new insights into potential drug targets.

SourceUniversity of Bonn·JournalJournal of Experimental Medicine·TypeExperimental study·DateAug 24, 2022

A warming planet could mess with our sleep – and make us more vulnerable to infectious disease

Research suggests rising temperatures could disrupt sleep patterns and blunt the immune response, making people more susceptible to infections. This is particularly concerning for low-income communities and communities of color who face heightened risks from heat and limited access to air conditioning.

SourceUniversity of California - Los Angeles Health Sciences·JournalTemperature·TypeLiterature review·DateAug 18, 2022

Road signs for immune defense cells

A recent international study has shed light on the inner workings of the adaptive immune response, revealing how killer T cells recognize viral invaders using molecular road signs. The study highlights the crucial role of chaperones in ensuring the stability and longevity of these road signs, allowing for more effective detection and d...

SourceGoethe University Frankfurt·JournalNature Communications·TypeExperimental study·DateAug 15, 2022